Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
Starting January 1, 2027, Lilly’s Zepbound (tirzepatide), Mounjaro (tirzepatide), and orforglipron, if approved, will be available through participating Medicare Part D plans
CagriSema produced a 23% weight loss at 84 weeks, versus 25.5% for tirzepatide
In 2025, over 1 million patients accessed Lilly treatments through LillyDirect
The trial targeted a patient population with high BMI and extensive skin involvement, averaging over 39 kg/m²
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
